Literature DB >> 9252158

Hepatic expression of inducible nitric oxide synthase transcripts in chronic hepatitis C virus infection: relation to hepatic viral load and liver injury.

S Mihm1, A Fayyazi, G Ramadori.   

Abstract

Hepatitis C virus (HCV) causes acute and often also chronic liver disease. Hepatocellular injury might result from both a host response directed to inhibit viral spread and from processes initiated by the virus itself. To study mechanisms involved in hepatocellular injury, liver tissue from chronically HCV-infected patients was analyzed for the expression of the inducible isoform of nitric oxide synthase (iNOS) and for interferon gamma (IFN-gamma) by a quantitative, competitive reverse-transcription-polymerase chain reaction (RT-PCR) technique. Moreover, hepatic viral load was determined by two independent techniques, and liver tissue was evaluated histopathologically in detail. Liver tissue from HCV-infected patients was shown to express elevated levels of iNOS transcripts compared with non-HCV-infected patients. Increased iNOS transcript expression, however, was not accompanied by significantly elevated serum nitrite plus nitrate (NOx) concentration, although some of the chronic HCV-infected patients reached markedly higher serum NOx levels than the control group or healthy individuals, respectively. Hepatic iNOS expression was found to be positively correlated to hepatic HCV-RNA content on the one hand, and weakly to hepatic IFN-gamma expression, previously shown to be solely associated with hepatic necro-inflammatory activity among the histopathological parameters studied, on the other hand. In contrast to IFN-gamma transcript expression, neither hepatic iNOS expression nor hepatic HCV-RNA content were related to hepatic inflammatory activity. The presented data are compatible with the assumption that HCV might be able to stimulate iNOS expression both directly and indirectly via its capacity to induce IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9252158     DOI: 10.1002/hep.510260228

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  15 in total

1.  Distribution of nitric oxide synthase in normal and cirrhotic human liver.

Authors:  Lance McNaughton; Lakshmi Puttagunta; Maria Angeles Martinez-Cuesta; Norm Kneteman; Irvin Mayers; Redwan Moqbel; Qutayba Hamid; Marek W Radomski
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

2.  Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization.

Authors:  R Patzwahl; V Meier; G Ramadori; S Mihm
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.

Authors:  Daniel Sepulveda-Crespo; Salvador Resino; Isidoro Martinez
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

4.  Liver infiltrating T lymphocytes express interferon gamma and inducible nitric oxide synthase in chronic hepatitis C virus infection.

Authors:  S Schweyer; S Mihm; H J Radzun; H Hartmann; A Fayyazi
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

Review 5.  Nitric oxide in liver diseases.

Authors:  Yasuko Iwakiri; Moon Young Kim
Journal:  Trends Pharmacol Sci       Date:  2015-05-28       Impact factor: 14.819

Review 6.  Asymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosis.

Authors:  Paloma Lluch; Gloria Segarra; Pascual Medina
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

Review 7.  DNA methylation in gastric cancer, related to Helicobacter pylori and Epstein-Barr virus.

Authors:  Keisuke Matsusaka; Sayaka Funata; Masashi Fukayama; Atsushi Kaneda
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

8.  Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes.

Authors:  Keigo Machida; Kevin T-H Cheng; Vicky M-H Sung; Ki Jeong Lee; Alexandra M Levine; Michael M C Lai
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

9.  Interferon β (IFN-β) Production during the Double-stranded RNA (dsRNA) Response in Hepatocytes Involves Coordinated and Feedforward Signaling through Toll-like Receptor 3 (TLR3), RNA-dependent Protein Kinase (PKR), Inducible Nitric Oxide Synthase (iNOS), and Src Protein.

Authors:  Liyong Zhang; Wenpei Xiang; Guoliang Wang; Zhengzheng Yan; Zhaowei Zhu; Zhong Guo; Rajib Sengupta; Alex F Chen; Patricia A Loughran; Ben Lu; Qingde Wang; Timothy R Billiar
Journal:  J Biol Chem       Date:  2016-05-17       Impact factor: 5.157

Review 10.  Ribavirin in cancer immunotherapies: controlling nitric oxide augments cytotoxic lymphocyte function.

Authors:  Richard E Kast
Journal:  Neoplasia       Date:  2003 Jan-Feb       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.